Stock Notes

Rubicon Research

Every Finvezto stock note on Rubicon Research, dated and newest first. Coverage spans pharma.

1 note and counting
22 Jul 2026
Rubicon Research bought its first US manufacturing plant, at East Brunswick in New Jersey, at an enterprise value of 2.9 million dollars.
Subsidiary AdvaGen won it through a court supervised bankruptcy sale of InvaTech Pharma. The site makes oral solid and liquid formulations and shares a wall with Rubicon's existing US distribution centre. Production starts in calendar 2027.
Finvezto Membership

Get the research behind the notes

Stock notes are the free daily layer. The membership carries the full Flexi-Wealth system: an ETF core portfolio with monthly rebalancing signals, fifteen quality-momentum stocks with exact weightages every month, options income and hedging recommendations, and the institutional data toolkit. One flat membership covers everything.

Become a Member Read free sample research →

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.